Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-021154

INTERIM PRESIDENT AND CEO acquired 43,548 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal INTERIM PRESIDENT AND CEO 2024-08-09 Option exercise +43,548 $0.72 $31,355 1,356,153 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal INTERIM PRESIDENT AND CEO 2024-08-09 Option exercise · Employee Stock Option (right to buy) −43,548 0 D: show line 2 in the form
Loading xslF345X05/form4-08132024_040801.xml…